Canadian Hospital Specialties Limited Joins AdvaMed®, the World’s Leading Medical Technology Trade Association
- Canadian Hospital Specialties Limited
February 9, 2022 — Canadian Hospital Specialties Limited (CHS) announced today that it has joined the Advanced Medical Technology Association® (AdvaMed®), the world’s leading trade association representing more than 400 medical device manufacturers around the world. Read more…
Related Reading
Resource / Diagnostics / Regulatory Affairs
Clinical Evidence for IVD Medical Devices
May 22, 2026
AdvaMed’s feedback on the CEIVD draft outlines targeted recommendations to improve clarity in clinical evidence expectations for IVD devices, including more precise terminology, alignment with global frameworks, and clearer distinctions between real-world data and evidence.
Blog / Coverage & Payment / Diagnostics / Health Access
Earlier Answers, Better Care: How Expanded Access to Alzheimer’s Testing Can Change Lives
May 5, 2026
Early Alzheimer’s blood tests are improving diagnosis, but access depends on policy. Learn how expanded Medicare coverage is changing patient outcomes.
Blog / Emerging Policy Response Resources / Global & Trade / Tariffs
IEEPA Tariff Refunds Summary – What MedTech Companies Need to Know
April 29, 2026
After the Supreme Court struck down IEEPA tariffs, CBP launched the CAPE system to process refunds. Here’s what importers need to know about eligibility, submission, and timing.
Blog / Artificial Intelligence (AI) / Diagnostics / Digital Health / Health Access
The Insight Series: AI & Digital Health
April 24, 2026
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery. Our latest edition features Carlos Nunez, Chief Medical Officer at Resmed.
Resource / AdvaMed Advancements / Emerging Policy Response Resources / Global & Trade / Tariffs
AdvaMed® Advancements: Q1 2026 Report
April 24, 2026
Explore AdvaMed®’s Q1 2026 report on medtech policy, regulatory trends, reimbursement, and advocacy driving innovation and patient access.
Event / Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Supply Chain / Tariffs
IEEPA Tariff Refunds Are Coming: What Medtech Needs to Know
Now On-Demand
The U.S. Supreme Court recently marked a significant shift in the tariff landscape, learn what that means for your organization.
Blog / Artificial Intelligence (AI) / Diagnostics / Digital Health / Health Access
The Insight Series: AI & Digital Health
March 30, 2026
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery. Our latest edition features Julia Strandberg, Executive Vice President, Chief Business Leader, Connected Care at Philips.
News / Diagnostics / Health Access / Medical Imaging
AdvaMed® Announces Opening Nominations for its 2026 Lifetime Achievement, Dx Lifetime of Leadership & Service, and theAdvaMed® Imaging Röntgen Awards
March 4, 2026
WASHINGTON—AdvaMed® announced today that nominations for its 2025 Lifetime Achievement Award as well as the AdvaMedDx Lifetime of Leadership & Service Award and theAdvaMed® Imaging Röntgen Award are open through April 10. All three of these annual awards will be presented during The MedTech Conference, Oct.18-21, 2026, in Boston.